MedicinesPatentPool

MedicinesPatentPool

Communities at the heart of access: celebrating the first CAP term and looking ahead
Communities at the heart of access: celebrating the first CAP term and looking ahead
As the first three-year term of the Medicines Patent Pool’s (MPP) Community Advisory Panel (CAP) has come to a close for most CAP members, we would like to extend our sincere thanks to all members ...
🎥 #3 Tutorial - Discover the Advanced Filters
🎥 #3 Tutorial - Discover the Advanced Filters
Continuing our mission to help users make the most of the enhanced MedsPaL platform, we’re pleased to introduce a new mini‑tutorial in our 2026 series. This short video focuses on the Advanced Filt...
VIF World 2026 MPP Side Event: mRNA Programme: Building Sustainability through Partnerships
VIF World 2026 MPP Side Event: mRNA Programme: Building Sustainability through Partnerships
Organised by the Medicines Patent Pool (MPP), co-facilitated with the World Health Organization (WHO), this session brought together leading stakeholders from across the mRNA ecosystem to explore t...
World TB Day 2026 - Ending TB Together
World TB Day 2026 - Ending TB Together
On World TB Day 2026, this video highlights the urgent need to end tuberculosis through innovation, access, and global solidarity. Dr Oanh from the Centre for Supporting Community Development Init...
Polyvac – Science, Commitment, and Community: Women at the Forefront of Vaccine Innovation
Polyvac – Science, Commitment, and Community: Women at the Forefront of Vaccine Innovation
This year, we are delighted to share the voice of Ngo Thu Huong, Vice Director of Polyvac in Vietnam.  In this short film, she offers a glimpse into Polyvac’s journey —
The 16 manufacturing partners entering Phase 2.0 of the mRNA Tcehnology Transfer Programme
The 16 manufacturing partners entering Phase 2.0 of the mRNA Tcehnology Transfer Programme
The 16 manufacturing partners who have joined the mRNA Technology Programme since 2021will enter Phase 2.0 in 2026. A great opportunity to move forward with the application of the mRNA technology r...
🎥 #2 Tutorial - Discover the Licences Tab in MedsPaL
🎥 #2 Tutorial - Discover the Licences Tab in MedsPaL
Continuing our mission to help users navigate the enhanced MedsPaL platform, we’re excited to share the second mini tutorial in our 2025 series. This video dives into the Licences tab-highlightin...
#LicensingSavesLives - Pushing the boundaries of global health access
#LicensingSavesLives - Pushing the boundaries of global health access
Around the world, millions of people cannot access the medicines they need — not because the treatments don’t exist, but because they remain out of reach. At the Medicines Patent Pool, we work to c...
#mRNATechnology Transfer Programme High Level Event on 21 October 2025 in Brussels
#mRNATechnology Transfer Programme High Level Event on 21 October 2025 in Brussels
https://medicinespatentpool.org/news-publications-post/who-and-mpp-launch-phase-2-0-of-the-mrna-technology-transfer-programme On 21 October 2025, the Government of Belgium, the Medicines Patent Po...
Expanding access to long-acting HIV therapy in low-income and middle-income countries
Expanding access to long-acting HIV therapy in low-income and middle-income countries
Taking HIV treatment daily is not just a routine, it may be a struggle. For many like Nancy, the emotional and physical toll of taking pills every day can be overwhelming. Long-acting injectable
mRNA Programme Partners answer the question: "What will you do with mRNA technology?"
mRNA Programme Partners answer the question: "What will you do with mRNA technology?"
On the side lines of the G20, Medicines Patent Pool and the World Health Organization held an event on 12 June 2025 in Johannesburg, titled “Achieving Sustainable Pandemic Preparedness by Design: T...
mRNA Technology Transfer Programme’s Phase 2.0 on the sidelines of #g20 Summit
mRNA Technology Transfer Programme’s Phase 2.0 on the sidelines of #g20 Summit
13 June 2025, Johannesburg – In parallel with the G20 Health Working Group, global health leaders are coming together in Johannesburg to set the foundation for a bold new phase of the mRNA Technolo...
#WHA78 High Level Event organized by the French Mission & MPP in Geneva - 19 May 2025
#WHA78 High Level Event organized by the French Mission & MPP in Geneva - 19 May 2025
This event titled "Building Resilience: Local and Regional Approaches to Pandemic Preparedness and Health Security" was organized by the Permanent Mission of France to the United Nations Office at ...
🎥 #1 Tutorial - MedsPaL Tutorial Series
🎥 #1 Tutorial - MedsPaL Tutorial Series
Welcome to the new MedsPaL Tutorial Series launched on the occasion of World IP Day 2025! In this first video, MPP’s Patent Information Officer, Zongyuan Tang, introduces MedsPaL, the Medicines P...
Expanding Access, Saving Lives: Join MPP's Mission
Expanding Access, Saving Lives: Join MPP's Mission
In this video, Charles Gore, Executive Director of the Medicines Patent Pool, shares the vital work MPP does and why they need your support to continue their mission. He explains how MPP, founded...
Reducing maternal mortality: The important role of heat-stable carbetocin in Senegal
Reducing maternal mortality: The important role of heat-stable carbetocin in Senegal
On the occasion of the International Day for Maternal Health and Rights, we publish this video in support of the World Health Organization's year-long campaign, "Healthy beginnings, hopeful futures...
Réduire la mortalité maternelle : Le rôle important de la carbétocine thermostable au Sénégal
Réduire la mortalité maternelle : Le rôle important de la carbétocine thermostable au Sénégal
À l'occasion de la Journée internationale de la santé et des droits maternels, nous publions cette vidéo en soutien à la campagne annuelle de l'Organisation mondiale de la santé, "Une bonne santé à...